Study analyzes RAI2 protein expression in invasive breast cancer tissues by IHC using our anti-RAI2 polyclonal antibody

April, 2021 (Department of Breast Surgery, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan)

Low retinoic acid-induced 2 (RAI2) expression was considered a marker of poor prognosis in breast cancer as of today.

Now, using our anti-RAI2 polyclonal antibody (HPA051054), a new study analyzes RAI2 protein expression in invasive breast cancer tissues by IHC.

The results suggest that RAI2 has a role in the metastasis of breast cancer and that RAI2 expression could actually be used as a promising candidate biomarker of prognosis in breast cancer patients.

Article: https://lnkd.in/dNKSTMn

Anti-RAI2: https://lnkd.in/dkAkbaC